Group items tagged

The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership. The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from best practice. The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will produce recommendations for the future of pharmacy professional leadership in the UK. The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at University College London's Medical School. The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and develop its work. A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be hosted on Thursday 8 September 7-8:30 pm.

Pharmacy Business and Haleon jointly hosted a practical Pain Management webinar on 5 December 2023. The webinar was specially designed to empower community pharmacies with effective strategies for understanding, managing, and reducing pain in their patients' daily life. Pharmacist Faheem Ahmend, director at Health Clinic & MEDLRN, and Linda Perry, account relationship manager OTC at Haleon, engaged in an insightful and informative conversation, highlighting real issues in the pharmacy setting and practical solutions to support community pharmacists.

Dementia and Alzheimer's disease remained the leading cause of death in England and Wales in 2023, maintaining the pre-pandemic trend, according to the latest data from the Office for National Statistics (ONS). The figures reveal that there were 66,876 deaths with an underlying cause of dementia and Alzheimer's disease, accounting for 11.6% of all deaths registered that year. In response to this growing health concern, Luye Pharma is hosting a free special educational webinar on 6 November 2024 (timing: 18:30 - 20:00) for healthcare professionals. Titled "Treating Dementia in 2024: Optimising Pathways Between Primary and Secondary Care," the online session will focus on addressing the ever-increasing challenges in dementia treatment and how to optimise pathways between primary and secondary care. The webinar will feature expert speakers from the field of dementia care, including Dr. Jill Rasmussen, Primary Care Specialist in dementia, mental health, and intellectual disabilities; Delia Bashara, Consultant Pharmacist for the Mental Health of Older Adults and Dementia at South London and Maudsley NHS Foundation Trust; and Khaleel Loonat, Senior Clinical Pharmacist and Advanced Clinical Practitioner.

PAGB, the consumer healthcare association, has launched a new eLearning platform, open to both members and non-members, offering a comprehensive range of online training and development resources for the consumer healthcare industry. Launched at the end of 2024, the eLearning platform was initially exclusive to PAGB members. It has now been expanded to include non-members, along with the addition of new content and courses. Fully integrated with PAGB's website, the eLearning platform provides a variety of on-demand training courses and webinar recordings, complementing the association's year-round schedule of workshops and events. From Essentials courses that cover foundational topics such as UK medicines regulations, to Deep Dive courses offering in-depth knowledge on specific areas like CBD and novel food, the eLearning content is designed to support users' professional development and expertise. Additionally, the platform offers a collection of webinar recordings from past events, offering insights into various areas of consumer healthcare and PAGB membership. These recordings are currently exclusive to PAGB members.